ReviewFrontiers in pharmacology2021

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota.

Shengjie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.